Of all proteins identified by SOMAscan® to be significantly altered in a cluster-specific manner, MDK was the only protein that qualified as a prognostic marker for poor outcome in GBM based on TCGA data (Figure 6A). This evidence concerns the gene MDK and glioblastoma.